Nigel S B RawsonDr. Nigel Rawson is pharmacoepidemiologist, pharmaceutical policy researcher, President of Eastlake Research Group in Oakville, Ontario, an affiliated scholar with the Canadian Health Policy Institute in Toronto, and a senior fellow with the Fraser Istitute in Vancouver, British Columbia. He has a BSc with first class honours, an MSc in statistics, and a PhD in pharmacoepidemiology.

Dr. Rawson has held academic positions at the University of London and the University of Southampton in the United Kingdom and at the University of Saskatchewan and Memorial University in Newfoundland in Canada. In the private sector, he has served as a senior researcher at the Center for Health Care Policy and Evaluation, an independent research group at one of the United States' largest health insurers, where he collaborated with the Food and Drug Administration on drug safety studies. He was also GlaxoSmithKline's only epidemiologist in Canada, providing advice and analysis for the company's current and developing products.

Dr. Rawson has performed epidemiological studies on the use of drugs and their outcomes for over thirty-five years and has published more than one hundred book chapters and articles in peer-reviewed journals. Read More Read Less